
NTEC
Kipco Tower Fl 28, Kuwait City, Al Asimah, Kuwait
Overview
NTEC is a leader in promoting sustainable transfer of technology to the region, through a corporate venture capital model. They invest in the following : * Biotechnology and Life Sciences * IT and Telecommunication * Energy and Alternate Energy * Water and Environment * Venture Capital Funds
- Total investments
- 3
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Oxford Immunotec
Participated · Equity · Jun 2012
Oxford Immunotec develops immunology-focused diagnostic tests based on its patented T‑SPOT technology, with its primary product being the T‑SPOT.TB test for latent tuberculosis. The company runs testing laboratory operations in both the US and the UK (Oxford Diagnostic Laboratories) and sells tests in kit form. T‑SPOT.TB is described as the first FDA‑approved method for directly quantifying antigen-specific T cells and has regulatory approval in over 40 countries. In the US the T‑SPOT.TB test has CPT code 86481 and recently increased CMS reimbursement of approximately $106 per test. The company intends to use new funding to expand sales and marketing for the T‑SPOT.TB test and to accelerate development and commercialization of additional infectious and immunological assays. Management highlights the market opportunity for latent TB testing and the company’s lab‑based US business model as drivers of growth. Oxford Immunotec develops and commercializes T cell–based diagnostic tests, most notably the laboratory-based T‑SPOT®.TB cellular blood test that diagnoses latent and active tuberculosis by measuring MTB‑specific T cells. The company is advancing its diagnostic product pipeline and using new capital to support ongoing commercialization of T‑SPOT®.TB. T‑SPOT®.TB is currently marketed in the United States, Europe, Canada and more than 40 other countries worldwide. Oxford Immunotec is based in Oxford, UK, with U.S. operations in Marlborough, MA. The company recently closed the second tranche of a $26M Series D financing to fund these activities.
- Petra Systems
Participated · Equity · Feb 2010
Petra Solar designs and supplies pole-mounted smart grid and solar systems for utility customers. The company recently raised $40M to support growth. It plans to use the financing to expand its customer base and accelerate hiring. Petra Solar intends to add 30 executive and professional employees immediately. By the end of 2010 the company expects to employ 165 people, a ten-fold increase from its base of 15 last spring. The firm is actively recruiting across the United States for project developers, regulatory experts, account managers, engineers and manufacturing staff.
Team
No current team members are available.